Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethylmorpholine | HCID 7525 | — |
| Reactant | Dicyclohexylcarbodiimide | HCID 10868 | — |
| Reactant | Ethylamine hydrochloride | HCID 11198 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | O-(1,1-Dimethylethyl)-N-((phenylmethoxy)carbonyl)-L-tyrosine | HCID 978520 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | Z-Tyr(But)-NH-C2H5 | HCID 131713304 | — |
Reaction Steps
3.2 ml (25 mmoles) of N-ethylmorpholine and 5.56 g (27 mmoles) of dicyclohexylcarbodiimide are added at 0° C. to a solution in 50 ml of dimethylformamide of 9.27 g (25 mmoles) of Z-Tyr(But)-OH, 2.03 g (25 mmoles) of ethylamine hydrochloride and 3.38 g of 1-hydroxybenzotriazole. The mixture is stirred for two hours at 0° C. and for 5 hours at room temperature and is left to stand overnight at room temperature. The precipitate is filtered off and the filtrate is concentrated. The resulting oil is partitioned between ethyl acetate and water. The ethyl acetate phase is extracted by shaking with KHSO4 solution, NaHCO3 solution and water, is dried over Na2SO4 and is concentrated. The residue cyrstallizes from petroleum ether. Yield 9.63 g (96% ), melting point 107°-110°, [α]D22 =-0.5° (c=1, methanol).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04420424 |
|---|
| Source dataset | uspto-grants-1983_12 |
|---|
| ORD ID | ord-2a09d53a72fd48b1bf7da69b3c192c25 |
|---|
| Source note | uspto-grants-1983_12 |
|---|